RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
研究项目 1:暴露和风险的化学和病毒生物标志物(Groopman)
基本信息
- 批准号:8278588
- 负责人:
- 金额:$ 48.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcysteineAflatoxin B1AflatoxinsAfricaAfrica South of the SaharaAgeApoptosisAsiaBiologicalBiological MarkersBloodCancer EtiologyCarcinogensCellsCessation of lifeChemicalsChemopreventionChinaChronicClinicalCodon NucleotidesCohort StudiesCommunitiesComplexDNADevelopmentDiagnosisDietDiseaseDoseEnvironmental ExposureEpidemiologic StudiesEpoxy CompoundsEquilibriumEtiologyExposure toGene MutationGeneticGoalsGuanineHBV and AflatoxinHepatitis BHepatitis B VirusHepatitis CHepatitis C virusHumanImidazoleIndividualInfectionInterventionIntervention TrialIsotopesKnowledgeLabelLysineMalignant NeoplasmsMalignant neoplasm of liverMeasuresMetabolic PathwayMethodologyMethodsMinorityMolecularMorbidity - disease rateMutationNucleotidesOrganOutcomePathogenesisPopulationPredispositionPrevalencePreventivePrimary carcinoma of the liver cellsProcessProgram Research Project GrantsProteinsRiskRisk FactorsRuralSerumShort Oligonucleotide Mass AnalysisSiteSolid NeoplasmThailandTimeToxic Environmental SubstancesTranslatingTumor Suppressor GenesViralViral GenesVirusWorkadductcohortdisorder riskenvironmental agenthigh riskhuman diseaseinnovationinsightmortalitynovelprogramsresponsesuccesstoxicanturinary
项目摘要
Hepatocellular carcinoma (HCC) is a major cause of cancer morbidity and mortality in many parts of Asia,
including China and Thailand, and in sub-Saharan Africa, where there are upwards of 600,000 new cases
and deaths each year. The impact of HCC is exacerbated by a median age of diagnosis of between 45 and
50 years and it is nearly always fatal. The major known etiological factors associated with development of
HCC in these regions are infection with hepatitis B (HBV) and/or hepatitis C (HCV) virus and lifetime
exposure to high levels of aflatoxin B1 (AFB1) in the diet. HCC is also the most rapidly rising solid tumor in
the US and is overrepresented in minority communities. While knowledge of the etiology of HCC has spurred
many mechanistic studies to understand the pathogenesis of this disease, this information is only just
beginning to be translated into development of preventive and clinical interventions in high risk populations.
The goals of this project are to develop and validate biomarkers reflecting the biological effects of exposures
to chemical and viral toxicants in the etiology of liver cancer. In all chronic human diseases, including cancer,
ambient exposures to multiple environmental agents are significant contributors. The specific aims of this
project are: 1) To develop validated isotope dilution LC-MS methods for urinary aflatoxin metabolites:
oxidized aflatoxins; aflatoxin mercapturic acid; the imidazole-ring opened FAPY adduct and aflatoxin-lysine
adducts; 2) To determine the power of mutations in hepatitis B virus (HBV) and p53 in serum DMA to predict
HCC risk in cohorts in rural China and West Africa; and 3) To extend our assessment of interactions among
hepatitis C virus (HCV), HBV and aflatoxin exposure as risk factors for HCC development in a cohort in
Northern Thailand. This project is working to develop innovative quantitatitive methods for biomarkers that
are applied to the assessment of the efficacy of both primary and chemoprevention interventions in high-risk
populations for HCC. These biomarkers have been and will continue to be validated using cohort studies and
their relation to disease risk will then be characterized.
肝细胞癌(HCC)是亚洲许多地方的癌症发病率和死亡率的主要原因,
包括中国和泰国,以及撒哈拉以南非洲,有60万个新案件
和每年死亡。 HCC的影响因诊断的中位年龄在45至
50年,几乎总是致命的。与发展有关的主要已知病因
这些区域的HCC是乙型肝炎(HBV)和/或丙型肝炎(HCV)病毒和寿命的感染
饮食中暴露于高水平的黄曲霉毒素B1(AFB1)。 HCC也是实体瘤最快上升的实体瘤
美国,在少数民族社区中代表过多。虽然对HCC病因的了解刺激了
许多理解该疾病发病机理的机械研究,此信息仅仅是
开始转化为高风险人群预防和临床干预的发展。
该项目的目标是开发和验证反映暴露的生物学作用的生物标志物
在肝癌病因中的化学和病毒毒性。在包括癌症在内的所有慢性人类疾病中
环境暴露于多种环境药物是重要的贡献者。这个特定的目的
项目是:1)为尿尿道毒素代谢物开发经过验证的同位素稀释LC-MS方法:
氧化的黄曲霉毒素;黄曲霉毒素苏联酸;咪唑环开放的Fapy加合物和黄曲霉毒素 - 赖氨酸
加合物; 2)确定丙型肝炎病毒(HBV)和p53在血清DMA中的功能以预测
中国农村和西非人群中的HCC风险; 3)扩展我们对互动的评估
丙型肝炎病毒(HCV),HBV和黄曲霉毒素暴露是HCC发展的风险因素
泰国北部。该项目正在努力为生物标志物开发创新的定量方法
应用于评估一级和化学预防干预措施在高危的疗效
HCC的种群。这些生物标志物已经并且将继续使用队列研究和
然后,它们与疾病风险的关系将被表征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John D Groopman其他文献
John D Groopman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John D Groopman', 18)}}的其他基金
Detoxication of Air Pollutants in Humans with a Broccoli Supplement
西兰花补充剂对人体空气污染物的解毒
- 批准号:
8885232 - 财政年份:2015
- 资助金额:
$ 48.62万 - 项目类别:
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
研究项目 1:暴露和风险的化学和病毒生物标志物(Groopman)
- 批准号:
8376299 - 财政年份:2012
- 资助金额:
$ 48.62万 - 项目类别:
Serum Biomarkers of Hepatic Response to Cancer Chemopreventive Intervention
肝脏对癌症化学预防干预反应的血清生物标志物
- 批准号:
7545518 - 财政年份:2008
- 资助金额:
$ 48.62万 - 项目类别:
Serum Biomarkers of Hepatic Response to Cancer Chemopreventive Intervention
肝脏对癌症化学预防干预反应的血清生物标志物
- 批准号:
7385183 - 财政年份:2008
- 资助金额:
$ 48.62万 - 项目类别:
相似国自然基金
Brevundimonas sp. LF-1代谢黄曲霉毒素B1的分子机制研究
- 批准号:32300088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Atox1抵御黄曲霉毒素B1致绵羊肝细胞DNA损伤的分子机制研究
- 批准号:32302822
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分子印迹型光催化材料靶向降解油脂中黄曲霉毒素B1的性能与机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于功能核酸适配体传感体系精准推断黄曲霉毒素B1入体时间的实验研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于铁死亡通路甘草查尔酮A抗黄曲霉毒素B1致雏鸡肝损伤的机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
研究项目 1:暴露和风险的化学和病毒生物标志物(Groopman)
- 批准号:
8376299 - 财政年份:2012
- 资助金额:
$ 48.62万 - 项目类别:
RESEARCH PROJECT 1: Chemical and Viral Biomarkers of Exposure and Risk (Groopman)
研究项目 1:暴露和风险的化学和病毒生物标志物(Groopman)
- 批准号:
7515836 - 财政年份:2008
- 资助金额:
$ 48.62万 - 项目类别:
MOLECULAR BIOMARKERS FOR ENVIRONMENTAL CARCINOGENS
环境致癌物的分子生物标志物
- 批准号:
7493911 - 财政年份:1993
- 资助金额:
$ 48.62万 - 项目类别:
Molecular Mechanisms of Chemoprevention: NRF2 Signaling
化学预防的分子机制:NRF2 信号传导
- 批准号:
8228086 - 财政年份:1985
- 资助金额:
$ 48.62万 - 项目类别:
Molecular Mechanisms of Chemoprevention: NRF2 Signaling
化学预防的分子机制:NRF2 信号传导
- 批准号:
8444566 - 财政年份:1985
- 资助金额:
$ 48.62万 - 项目类别: